Table 5.
EORTC QLQ‐C30 and STO22 scores and proportion of patients with improvement at 1 month after the completion of RT (n = 16)
| Baseline | 1 month after the completion of RT | Patients with improvement, n (%) | |
|---|---|---|---|
| Mean (SD) | Mean (SD) | ||
| EORTC QLQ‐C30 | |||
| Physical functioninga | 66.7 (23.0) | 65.8 (28.7) | 7 (43.8) |
| Role functioninga | 66.7 (29.8) | 65.6 (37.7) | 6 (37.5) |
| Emotional functioninga | 87.0 (13.9) | 82.8 (27.6) | 1 (6.3) |
| Cognitive functioninga | 91.7 (10.5) | 92.7 (14.9) | 5 (31.3) |
| Social functioninga | 74.0 (21.9) | 75.0 (32.2) | 7 (43.8) |
| Fatigue a | 41.7 (20.1) | 33.3 (27.8) | 10 (62.5) |
| Nausea/vomiting a | 15.6 (23.1) | 9.4 (14.9) | 5 (31.3) |
| Pain a | 32.3 (32.5) | 17.7 (27.5) | 8 (50.0) |
| Dyspneaa | 10.4 (26.4) | 0.0 (0.0) | 3 (18.8) |
| Insomniaa | 25 (37.5) | 12.5 (24.0) | 5 (31.3) |
| Appetite lossa | 29.2 (31.9) | 41.7 (31.0) | 2 (12.5) |
| Constipationa | 22.9 (33.8) | 20.8 (20.6) | 5 (31.3) |
| Diarrheaa | 6.3 (18.1) | 6.3 (13.4) | 1 (6.3) |
| Financial problemsa | 27.1 (32.7) | 20.8 (34.2) | 4 (25.0) |
| Global health status/quality of lifea | 60.9 (18.2) | 53.1 (26.0) | 5 (31.3) |
| STO22 | |||
| Body imagea | 81.3 (32.1) | 85.4 (34.4) | 3 (18.8) |
| Dysphagia a | 22.2 (19.9) | 18.8 (18.9) | 7 (43.8) |
| Pain a | 16.1 (23.9) | 19.3 (27.8) | 3 (18.8) |
| Reflux symptomsa | 15.3 (22.5) | 10.4 (13.1) | 6 (37.5) |
| Eating restrictionsa | 26.0 (23.5) | 24.0 (28.2) | 5 (31.3) |
| Anxietya | 25.7 (34.8) | 16.0 (30.6) | 6 (37.5) |
| Dry moutha | 20.8 (24.0) | 18.8 (29.7) | 5 (31.3) |
| Taste problema | 20.8 (29.5) | 14.6 (24.3) | 3 (18.8) |
| Hair lossa | 14.3 (36.3) | 8.9 (15.3) | 2 (14.3) |
Domains of interest are italicized.
SD, standard deviation.
A high score represents high response level.
a
A high score represents high symptom level.